Event: Psilocybin Therapy for Bipolar Disorder ⏰ Tuesday 16 April, 8PM CET (7PM GMT, 2PM EST, 11AM PST)

Researchers at Maryland University have completed an early phase clinical trial to asses the feasibility and preliminary outcomes of treating Bipolar II Disorder with single-dose synthetic psilocybin. Specifically, this recently published study treated patients with a BD II diagnosis in a current de...